Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221.4 USD | +1.80% | +2.75% | -14.43% |
05-06 | People with two copies of a risk gene have genetic form of Alzheimer's, scientists say | RE |
05-03 | HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.43% | 32.24B | |
-2.47% | 88.14B | |
+1.45% | 40.44B | |
+52.34% | 24.39B | |
-14.85% | 15.59B | |
-13.87% | 12.14B | |
-7.87% | 12.18B | |
-39.40% | 12.3B | |
+4.64% | 8.87B | |
-6.67% | 8.41B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Morgan Stanley Adjusts Price Target on Biogen to $345 From $325, Maintains Overweight Rating